62 related articles for article (PubMed ID: 30868858)
21. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
Jentschke M; Soergel P; Hillemanns P
J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
[TBL] [Abstract][Full Text] [Related]
22. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay.
Rebolj M; Preisler S; Ejegod DM; Bonde J; Rygaard C; Lynge E
J Mol Diagn; 2013 Sep; 15(5):670-7. PubMed ID: 23827659
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears.
Jun SY; Park ES; Kim J; Kang J; Lee JJ; Bae Y; Kim SI; Maeng LS
PLoS One; 2015; 10(10):e0140336. PubMed ID: 26469982
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
Ki EY; Lee YK; Lee A; Park JS
Yonsei Med J; 2018 Jul; 59(5):662-668. PubMed ID: 29869464
[TBL] [Abstract][Full Text] [Related]
27. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
28. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.
Polman NJ; Oštrbenk A; Xu L; Snijders PJF; Meijer CJLM; Poljak M; Heideman DAM; Arbyn M
J Clin Microbiol; 2017 Dec; 55(12):3544-3551. PubMed ID: 29021152
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology.
Rebolj M; Lynge E; Ejegod D; Preisler S; Rygaard C; Bonde J
Gynecol Oncol; 2014 Dec; 135(3):474-80. PubMed ID: 25449563
[TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media.
Jang D; Ratnam S; Smieja M; Speicher DJ; Arias M; Clavio A; Costescu D; Elit L; Huang S; Herrero-Garcia E; Joseph AM; Jiang H; Needle R; Chernesky M
Tumour Virus Res; 2021 Dec; 12():200224. PubMed ID: 34242835
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic.
Keegan H; Pilkington L; McInerney J; Jeney C; Benczik M; Cleary S; von Bunau G; Turner M; D'Arcy T; O' Toole S; Pal-Szenthe B; Kaltenecker B; Mózes J; Kovács A; Solt A; Bolger N; O'Leary J; Martin C
J Virol Methods; 2014 Jun; 201():93-100. PubMed ID: 24583109
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS
Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740
[TBL] [Abstract][Full Text] [Related]
35. EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1033-6. PubMed ID: 27048314
[TBL] [Abstract][Full Text] [Related]
36. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
37. Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.
Naryshkin S; Austin RM
Drug Healthc Patient Saf; 2012; 4():167-72. PubMed ID: 23152707
[TBL] [Abstract][Full Text] [Related]
38. Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.
Gilbert L; Oates E; Ratnam S
J Clin Microbiol; 2013 Oct; 51(10):3412-4. PubMed ID: 23903540
[TBL] [Abstract][Full Text] [Related]
39. HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions.
Bottari F; Iacobone AD; Radice D; Preti EP; Preti M; Franchi D; Boveri S; Sandri MT; Passerini R
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292048
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens.
Martin IW; Steinmetz HB; Lefferts CL; Dumont LJ; Tafe LJ; Tsongalis GJ
Pathogens; 2012 Sep; 1(1):30-6. PubMed ID: 25436602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
